富信科技(688662.SH):公司生產的Micro TEC產品已與國外友商同類產品處於同一水平區間
格隆匯8月4日丨富信科技(688662.SH)近期在接待機構投資者調研時表示,對於性能、尺寸及可靠性要求較高的高性能微型熱電器件來説,需要經過長時間的研發測試和技術積累才能達到相應的性能指標要求,且產業化生產又需要足夠的高端自動化設備、精密加工設備和熟練技術工人。國外友商如日本的Ferrotec、KELKLtd等企業深耕半導體熱電行業多年,具有豐富的行業經驗且工藝成熟。
公司近年來通過不斷的研發投入和積累,在關鍵核心技術上實現突破,並依靠自身完善的質量體系和豐富的製造經驗,逐步縮小與國外友商的差距,生產的Micro TEC產品已與國外友商同類產品處於同一水平區間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.